Position in SVRA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$217,624
New position
Shares Held
39,858
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#110
of 184 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026nVerses Capital, LLC holds $2,897,783 across 16 Biotechnology names. SVRA ranks #6 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
8,978 | $430,674 | |
| 2 | VCEL |
Vericel Corp
|
12,842 | $413,127 | |
| 3 | INVA |
Innoviva, Inc.
|
15,888 | $370,190 | |
| 4 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
38,236 | $295,181 | |
| 5 | FTRE |
Fortrea Holdings Inc.
|
24,379 | $229,650 | |
| 6 | SVRA |
Savara Inc
This page
|
39,858 | $217,624 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
22,364 | $201,499 | |
| 8 | OMER |
Omeros Corp
|
14,404 | $152,106 |
All Filings in SVRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $217,624 | 39,858 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||